Skip to main content

Chirurgische Therapie primärer maligner Lebertumoren

  • Chapter
  • 4437 Accesses

Zusammenfassung

Die Entwicklung der hepatobiliären Chirurgie als eigenes Spezialgebiet reflektiert die zunehmende Weiterentwicklung in der operativen Therapie der Lebermalignome. Die Zunahme der Chirurgie der Lebertumoren beruht zum einen auf einem Anstieg der Inzidenz sowie einer verbesserten Diagnostik, zum anderen auf anhaltendem Enthusiasmus über den Erfolg chirurgischen Vorgehens als Teil multimodaler Therapie, um auch in scheinbar inkurablen Situationen eine Tumorreduktion zu erreichen. Des Weiteren sind in den letzten 30 Jahren einige neue Tumorkategorien erkannt und neue ätiologische Faktoren für die Malignomentstehung identifiziert worden

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   269.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232: 777

    Article  CAS  PubMed  Google Scholar 

  • Arii S, Yamaoka Y, Futagawa S et al. (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 32: 1224

    Article  CAS  PubMed  Google Scholar 

  • Azoulay D, Castaing D, Krissat J et al. (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232: 665

    Article  CAS  PubMed  Google Scholar 

  • Balaton AJ, Nehama-Sibony M, Gotheil C et al. (1988) Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and cytokeratin 19 on paraffin sections. J Pathol 156: 305–310

    Article  CAS  PubMed  Google Scholar 

  • Bechtel D (1989) Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: linear correlation with hepatic cancer risk. Regul Toxicol Pharmacol 10: 74

    Article  CAS  PubMed  Google Scholar 

  • Belghiti J, Cortes A, Abdalla EK et al. (2003) Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 238: 885–893

    Article  PubMed  Google Scholar 

  • Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F (1999) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214: 114

    Article  Google Scholar 

  • Benckert C, Jonas S, Cramer T et al. (2003) Transforming growth factor β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res 63: 1083–1092

    CAS  PubMed  Google Scholar 

  • Boutron M, Faivre J, Milan C et al.(1988) Primary liver cancer in Cote d’Or (France). Int J Epidemiol 17: 21

    Article  CAS  PubMed  Google Scholar 

  • Broome U, Olsen R, Loof L et al. (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38: 610

    Article  CAS  PubMed  Google Scholar 

  • Bruix J (1997) Treatment of hepatocellular carcinoma. Hepatology 25: 259–262

    Article  CAS  PubMed  Google Scholar 

  • Bruix J, Sherman M, Llovet JM et al. (2001) Clinical management of hepatocellular carcinoma: conclusion of the Barcelona EASL Consensus Conference. J Hepatol 35: 421

    Article  CAS  PubMed  Google Scholar 

  • Capurro M, Wanless IR, Sherman M et al. (2003) Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125: 89–97

    Article  CAS  PubMed  Google Scholar 

  • Casavilla FA, Marsh JW, Iwatsuki S (1997) Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185: 429–436

    CAS  PubMed  Google Scholar 

  • Chairman, Strasberg SM, Belghiti J, Clavien P-A, Gadzijev E, Garden JO, Lau W-Y, Makuuchi M, Strong RW (2000) HPB 2: 333–339

    Google Scholar 

  • Chen MF (1999) Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol 14: 1144–1149

    Article  CAS  PubMed  Google Scholar 

  • Chen MS, Li JQ, Zheng Y et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321–328

    Article  PubMed  Google Scholar 

  • Chu KM, Fan ST (1999) Intrahepatic cholangiocarcinoma in Hong Kong. J Hepatobiliary Pancreat Surg 6: 149–153

    Article  CAS  PubMed  Google Scholar 

  • Clavien PA, Yadav S, Sindram D, Bentley RC (2000) Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232: 155–162

    Article  CAS  PubMed  Google Scholar 

  • Curley SA, Levin B, Rich TA (1995) Management of specific malignancies: liver and bile ducts. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds) Clinical oncology. Churchill Livingstone, New York, pp 1305–1372

    Google Scholar 

  • Di Bisceglie AM (1995) Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 15: 64

    Article  PubMed  Google Scholar 

  • Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 7: 462–503

    Article  CAS  PubMed  Google Scholar 

  • El-Serag HB, Davila JA (2004) Is fibrolameelar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 39: 798–803

    Article  PubMed  Google Scholar 

  • Fava G, Marzioni M, Benedetti A, Glaser S, DeMorrow S, Francis H et al. (2007) Molecular pathology of biliary tract cancers. Cancer Lett 250: 155–167

    Article  CAS  PubMed  Google Scholar 

  • Flavell DJ (1981) Liver-fluke infection as an aetiologic factor in bileduct carcinoma of man. Trans R Soc Trop Med Hyg 75: 814–823

    Article  CAS  PubMed  Google Scholar 

  • Fong Y, Sun R, Jarnagin W, Blumgart L (1999) An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 229: 790–800

    Article  CAS  PubMed  Google Scholar 

  • Ganjei P, Nadji M, Albores-Saavedra J, Morales AR (1988) Histologic markers in primary and metastatic tumors of the liver. Cancer 62: 1994–1998

    Article  CAS  PubMed  Google Scholar 

  • Goldzieher M, von Bokay Z (1911) Der primäre Leberkrebs. Virchows Arch 203: 75–131

    Article  Google Scholar 

  • Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ et al. (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8(2): 128–135

    Article  CAS  PubMed  Google Scholar 

  • Harada T, Matsuo K, Inoue T et al. (1996) Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 224: 4

    Article  CAS  PubMed  Google Scholar 

  • Harris CC, Hollstein M (1993) Clinical implications of the p53 tumorsuppressor gene. New Engl J Med 329: 1318–1327

    Article  CAS  PubMed  Google Scholar 

  • Hasan F, Jeffers ZJ, De Medina M et al. (1990) Hepatitis C-associated hepatocellular carcinoma. Hepatology 12: 589

    Article  CAS  PubMed  Google Scholar 

  • Hayashi K, Kumada T, Nakano S et al. (1999) Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol 94: 3028–3033

    CAS  PubMed  Google Scholar 

  • Henry SH, Bosch FX, Troxell TC, Bolger PM (1999) Reducing liver cancer-global control of aflatoxin. Science 286: 2453–2454

    Article  CAS  PubMed  Google Scholar 

  • Imamura H, Matsuyama Y, Tanaka E et al. (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38: 200–207

    Article  PubMed  Google Scholar 

  • Inoue M, Kurahashi N, Iwasaki M, Tanaka Y, Mitokami M, Noda M et al. (2009) Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II). Cancer Causes Control 20: 741–750

    Article  PubMed  Google Scholar 

  • Isa T, Kusano T, Shimoji H, Takeshita Y (2001) Predictive factors for longterm survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 181: 507–511

    Article  CAS  PubMed  Google Scholar 

  • Iwatsuki S, Dvorchik I, Marsh JW et al. (2000) Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Ann Coll Surg 191: 389–394

    Article  CAS  Google Scholar 

  • Izumi R, Shinizu K, Kiriyama M, Yagi M, Matsui O, Nonomura A, Miyazaki I (1995) Long-term survival of peripheral intrahepatic cholangiocarcinoma with distant metastasis. Am J Gastroenterol 90: 505–507

    CAS  PubMed  Google Scholar 

  • Jaeckel E, Cornberg M, Wedeneyer H et al. (2001) Treatment of a acute hepatitis C with interferon alfa-2b. N Engl J Med 345: 1452–1457

    Article  CAS  PubMed  Google Scholar 

  • Johnson PJ (1999) Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. Gastroenterol hepatol 14[Suppl]: S32–S36

    Google Scholar 

  • Johnson PJ, Poon TC, Hjelm NM, Ho CS, Blake C, Ho SK (2000) Structures of disease-specific serum alpha-fetoprotein isoforms. Br J Cancer 83: 1330–1337

    Article  CAS  PubMed  Google Scholar 

  • Jonas S, Al-Abadi H, Benckert C, Thelen A, Saribeyoglu K, Radtke B et al. (2009) Prognostic significance of the DNA-index in liver transplantation for hepatocellular carcinoma in cirrhosis. Ann Surg (in press)

    Google Scholar 

  • Jonas S, Bechstein WO, Steinmüller T et al. (2001) Vascular invasion and histopathological grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33: 1080

    Article  CAS  PubMed  Google Scholar 

  • Jonas S, Steinmüller T, Settmacher U et al. (2001) Liver transplantation for recurrent hepatocellular carcinoma in Europe. J Hepatobiliary Pancreat Surg 8: 422–426

    Article  CAS  PubMed  Google Scholar 

  • Jonas S, Thelen A, Benckert C, Biskup W, Neumann U, Rudolph B et al. (2009) Extended liver resection for intrahepatic cholangiocarcinoma — a comparison of the prognosis accuracy of the 5th and 6th editions of the TNM classification. Ann Surg 249: 303–309

    Article  PubMed  Google Scholar 

  • Kim SH, Lim HK, Lee WJ et al. (2000) Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 25: 246

    Article  CAS  PubMed  Google Scholar 

  • Kim SK, Lim JH, Lee WJ et al. (2002) Detection of hepatocellular carcinoma: comparison of dynamic three-phase computed tomography images and four-phase computed tomography images using multidetector row helical computed tomography. J Comput Assist Tomogr 26: 691–698

    Article  PubMed  Google Scholar 

  • Kimura H, Nakajima T, Kagawa K, Deguchi T, Kakusui M, Katagishi T et al. (1998) Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. Liver 18: 14–19

    CAS  PubMed  Google Scholar 

  • Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinct and pathological features. Am J Med 38: 241–256

    Article  CAS  PubMed  Google Scholar 

  • Kluge R, Schmidt F, Caca K et al. (2001) Positron emission tomography with (18)F fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33: 1029–1035

    Article  CAS  PubMed  Google Scholar 

  • Koike Y, Shiratori Y, Sato S et al. (2000) Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus. Hepatology 32: 1216

    Article  CAS  PubMed  Google Scholar 

  • Kudo M (1999) Imaging diaprows off hepatocellular carcinomas and premalignant/borderline lesions. Semin Liver Dis 19: 291

    Article  Google Scholar 

  • Lee KT, Liu TS (2001) Altered muscin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas. Dig Dis Sci 46: 2166–2172

    Article  CAS  PubMed  Google Scholar 

  • Leevy CM, Popper H, Sherlock S (eds) (1976) Diseases of the liver and biliary tract. Standardization of nomenclature diagnostic, and diagnostic methodology. Fogarty International Center, Washington/DC

    Google Scholar 

  • Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. Am J Roentgenol 181: 819–827

    Google Scholar 

  • Livraghi T, Meloni F, Di Stasi M et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 47: 82–89

    Article  PubMed  Google Scholar 

  • Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma. The BCLC staging classification. Semin Liver Dis 19: 329–338

    Article  CAS  PubMed  Google Scholar 

  • Llovet JM, Real MI, Montana X et al. (2002) Chemoembolization improved survival of stringently selected patients with unresectable hepatocellular carcinoma. Lancet 359: 1734–1739

    Article  PubMed  Google Scholar 

  • Majno PE, Adam R, Bismuth H et al. (1997) Influence of preoperative transarterial lipiodole chemoembolization on resection and transplantation for hepatocellular carcinomas in patients with cirrhosis. Ann Surg 226: 688

    Article  CAS  PubMed  Google Scholar 

  • Mazzaferro V, Llovet JM, Miceli R et al. (2009) Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43

    Article  PubMed  Google Scholar 

  • Mazzaferro V, Regalia E, Doci R et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693

    Article  CAS  PubMed  Google Scholar 

  • Michalak TI, Pardoe IU, Coffin CS, Churchill ND, Freake DS, Smith P et al. (1999) Occult lifelong persistence of infectious hepadna virus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 29: 928–938

    Article  CAS  PubMed  Google Scholar 

  • Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R (1991) Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 32: 1369–1373

    Article  CAS  PubMed  Google Scholar 

  • Murakami T, Nakamura H, Tsuda K et al. (1995) Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study. J Magn Reson Imaging 5: 165

    Article  CAS  PubMed  Google Scholar 

  • Murakami, T, Kim T, Takamura M et al. (2001) Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 218: 763–767

    CAS  PubMed  Google Scholar 

  • Nagasue N, Kohno H, Tachibana M et al. (1999) Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte Class B and C cirrhosis. Ann Surg 229: 84–90

    Article  CAS  PubMed  Google Scholar 

  • Nakanuma Y, Terada T, Tanaka Y, Ohta G (1985) Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch 406: 45–58

    Article  CAS  Google Scholar 

  • Okuda K, Kojiro M, Okuda H (1993) Neoplasms of the liver. In: Schiff L, Schiff EG (eds) Diseases of the liver. Lippincott, Philadelphia, pp 1276–1279

    Google Scholar 

  • Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H et al. (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56: 918–928

    Article  CAS  PubMed  Google Scholar 

  • Ozturk M (1999) Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 19: 235–242

    Article  CAS  PubMed  Google Scholar 

  • Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay S, Powell J (eds) (1992) Cancer incidence in five continents (vol VI). International Agency for Research on Cancer, Lyon

    Google Scholar 

  • Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the Unted Staes. Hepatology 33: 1353–1357

    Article  CAS  PubMed  Google Scholar 

  • Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B (1995) Surgical treatment in proximal bile duct cancer: a single-center experience. Ann Surg 224: 628–638

    Article  Google Scholar 

  • Pinna AD, Iwatsuki S, Lee RG et al. (1997) Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 26: 877

    Article  CAS  PubMed  Google Scholar 

  • Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH et al. (2007) Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 45: 968–976

    Article  CAS  PubMed  Google Scholar 

  • Plentz RR, Schlegelberger B, Flemming P, Gebel M, Kreipe H, Manns MP et al. (2005) Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma. Hepatology 42:522–526

    Article  CAS  PubMed  Google Scholar 

  • Poon RT, Fan ST, Lo CM et al. (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: Long-term results of treatment and prognostic factors. Ann Surg 229: 216

    Article  CAS  PubMed  Google Scholar 

  • Rafanow IG (1936) Liver stones. Ann Surg 103: 580–594

    Article  Google Scholar 

  • Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchiano A, Fornari F et al. (2000) Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217: 119–126

    CAS  PubMed  Google Scholar 

  • Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P (2000) Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 24: 870–876

    Article  CAS  PubMed  Google Scholar 

  • Satarug S, Haswell-Elkins MR, Tsuda M et al. (1996) Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection. Carcinogenesis 17: 1075–1081

    Article  CAS  PubMed  Google Scholar 

  • Soyer P, Bluemke DA, Sibert A, Laissy JP (1995) Imaging of intrahepatic cholangiocarcinoma. Abdom Imaging 20: 126

    Article  CAS  PubMed  Google Scholar 

  • Steiner PE (1960) Cancer of the liver and cirrhosis in Trans-Saharan Africa and the United States of America. Cancer 13: 1085–1166

    Article  Google Scholar 

  • Strasberg SM, Belghiti J, Clavien PA et al. (2000) The Brisbane 2000 terminology of liver anatomy and resections. HBP 2: 333–339

    Google Scholar 

  • Taketa K, Endo Y, Sekiya C et al. (1993) A collaborative study for the evaluation of lectin-reactive alpha-fetoprotein in early detection of hepatocellular carcinoma. Cancer Res 53: 5419–5423

    CAS  PubMed  Google Scholar 

  • Tang Y, Yamashita Y et al. (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium-and fermoxidesenhanced MR imaging. Am J Roentgenol 172(6): 1547–1554

    CAS  Google Scholar 

  • Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A et al. (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48: 816–820

    Article  CAS  PubMed  Google Scholar 

  • The CLIP investigators (2000) Prospective validation of the score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31: 840–845

    Article  Google Scholar 

  • Torzilli G, Minagawa M, Takayama T et al. (1999) Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 30: 889

    Article  CAS  PubMed  Google Scholar 

  • Trojan J, Raedle J, Zeuzem S (1998) Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment. Digestion 59[Suppl2]: 72–74

    Article  PubMed  Google Scholar 

  • Tsuji T, Hiraka T, Kaneomitsu K, Takamori H, Tanabe D, Tashiro S (2001) Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery 129: 401–407

    CAS  PubMed  Google Scholar 

  • Uchida T, Shikata T, Tanaka E, Kiyosawa K (1994) Immunoperoxidase staining of hepatitis C virus in formalin-fixed, paraffin-embedded needle liver biopsies. Virchow Arch 424: 465–469

    CAS  Google Scholar 

  • Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Kinoshita H (2001) Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 88: 969–974

    Article  CAS  PubMed  Google Scholar 

  • Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G et al. (2007) Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 204: 1016–1027

    Article  PubMed  Google Scholar 

  • Weimann A, Varnholt H, Schlitt HJ et al. (2000) Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg 87: 1182–1187

    Article  CAS  PubMed  Google Scholar 

  • Wittekind C, Meyer HJ, Bootz F (2003) TNM-Klassifikation maligner Tumoren, 6. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 74–76

    Google Scholar 

  • Yamagiwa K (1911) Zur Kenntnis des primären parenchymatösen Leberkarzinoms («Hepatoms”). Virchows Arch Path Anat 206: 437–467

    Article  Google Scholar 

  • Yamamoto M, Ikai I, Kume M, Sakai Y (1999) New simple technique for hepatic parenchymal resection using CUSA and bipolar cautery equipped with a channel for water dripping. World J Surg 23: 1032–1037

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto M, Takasaki K, Nakano M, Saito A (1998) Minute nodular intrahepatic cholangiocarcinoma. Cancer 82: 2145–2149

    Article  CAS  PubMed  Google Scholar 

  • Yamashita Y, Mitsuzaki K, Yi T et al. (1996) Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200: 79

    CAS  PubMed  Google Scholar 

  • Yao SY, Ferrell L, Bass NM et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394–1403

    Article  CAS  PubMed  Google Scholar 

  • Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE (1991) Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 68: 2095

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Thelen, A., Benckert, C., Jonas, S. (2010). Chirurgische Therapie primärer maligner Lebertumoren. In: Siewert, J.R., Rothmund, M., Schumpelick, V. (eds) Praxis der Viszeralchirurgie Onkologische Chirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03808-2_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-03808-2_43

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-03807-5

  • Online ISBN: 978-3-642-03808-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics